Acute vulvar ulcer as a possible adverse event of gene‐based COVID ‐19 vaccines: A review of 14 cases
Journal of Obstetrics and Gynaecology Research · 2023-07 · 49 (7) · 1846-1853
DOI: 10.1111/jog.15647 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 17.04.2023. Verfasst von Hiromi Kanetani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Chiba Aoba Municipal Hospital. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Vulvar Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Aim
To evaluate whether an acute vulvar ulcer that developed after the COVID‐19 vaccine administration is an adverse effect of the vaccine.
Methods
This is a descriptive study of two cases that we observed in addition to cases that have been reported in the literature. We searched for case reports in the PubMed. The consistency of clinical manifestations among cases and the association between ulceration and vaccination were assessed.
Results
Fourteen female patients were identified, including 12 patients from 8 literatures published in 2021 and 2022 and 2 patients from our cases. Of the 14 patients, 11 had received the BNT162b2 vaccine, 2 had received the ChAdOx1 nCoV‐19 vaccine, and one had received the mRNA‐1273 vaccine. The patient's ages were 16.9 ± 5.0 (mean ± SD) years. Postvaccination, the disease progressed in the following sequence (time interval from vaccination): fever and other systemic inflammatory reactions (0.9 ± 0.4 days), development of vulvar ulcers (2.4 ± 1.2 days), and resolution of the ulcer (16.9 ± 7.4 days). The ulcers eventually healed in all cases, except one where the prognosis was not noted. For two‐dose vaccine recipients, more patients developed the ulcer after the full vaccination (the second or third doses) compared with after the first dose: n = 10 and n = 2, respectively.
Conclusion
The acute vulvar ulcer was closely associated with COVID‐19 vaccination in terms of temporality and vaccine doses, supporting the notion that a vulvar ulcer is an adverse event of the COVID‐19 vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Chiba Aoba Municipal Hospital.
- Reproductive Medicine, Chiba University Hospital, Chiba University, Chiba, Japan.
- Evolution and Reproductive Medicine, Medical Mycology Research Center, Chiba University, Chiba, Japan.
ORCID-Profile: Hiroshi Ishikawa, Makio Shozu
Zitieren
APA
Kanetani, H., Obuchi, T., Ishikawa, H., & Shozu, M. (2023). Acute vulvar ulcer as a possible adverse event of gene‐based COVID ‐19 vaccines: A review of 14 cases. Journal of Obstetrics and Gynaecology Research, 49(7), 1846-1853. https://doi.org/10.1111/jog.15647
Vancouver
Kanetani H, Obuchi T, Ishikawa H, Shozu M. Acute vulvar ulcer as a possible adverse event of gene‐based COVID ‐19 vaccines: A review of 14 cases. Journal of Obstetrics and Gynaecology Research. 2023;49(7):1846-1853. doi:10.1111/jog.15647
BibTeX
@article{Kanetani2023,
author = {Kanetani, Hiromi and Obuchi, Tomoka and Ishikawa, Hiroshi and Shozu, Makio},
title = {Acute vulvar ulcer as a possible adverse event of gene‐based COVID ‐19 vaccines: A review of 14 cases},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2023},
volume = {49},
number = {7},
pages = {1846--1853},
doi = {10.1111/jog.15647}
}
EUVIMED